1. Supplementary Table 1.
Dissociation cases of EI and Fibrosis
Case 1 2 3 4 5 6 7 8 9 10
Age 59 26 69 54 88 64 67
Sex M F
BMI
20.4
31.2
28.4
27.2
21.2
18.4
21.8
24.2
20.3
27.5
Etiology
HBV
NAFLD
HCV
AIH
HyA
53.3
22.8
51.5
20.9
52.9
1320
226
166
223
67.0
4C7
3.5
5.2
4.2
4.5
9.1
11.0
6.7
6.3
8.7
APRI
0.5
1.8
0.6
0.9
3.4
3.1
0.7
2.3
FIB-4
1.7
0.8
2.3
1.9
4.3
10.9
5.6
3.5
2.4
8.9 EI
3.0
3.8
4.2
4.5
2.6
2.4
Fibrosis F0 F1 F2 F3 F4
Method* Op Bp
M, male; F, female; BMI, body mass index; HBV, hepatitis B virus; HCV, hepatitis C virus; AIH, autoimmune hepatitis; NAFLD, non-alcoholic fatty liver disease; HyA, hyaluronic acid;
4C7, type 4 collagen 7S; APRI, aspartate aminotransferase to platelet ratio index; EI, elasticity index; HCC, hepatocellular carcinoma, Op, operation; Bp, liver biopsy.
Asterisk means the method to obtain liver histology. Operation had been performed for the treatment of HCC.

2. Supplementary Table 2.
Intraclass correlation coefficient (ICC) in strain elastography
Cohort
Whole cohort
HCV
HBV
AL/NAFLD n
193 88 41 35
Mean BMI
24.3
24.2
23.8
25.3*
ICC
0.835
0.859
0.792
0.703
95% confidential index
* Asterisk means statistically significant differences between AL/NAFLD group and other groups.
BMI, body mass index; HCV, hepatitis C virus; HBV, hepatitis B virus; AL, alcohol; NAFL, non-alcoholic fatty liver.

3. Supplementary Fig. 1 BCLC-O, A BCLC-B Cumulative survival rate BCLC-C
Survival time (months)
Cumulative survival rate
BCLC-O, A
BCLC-B
BCLC-C
BCLC-D
P<0.001 in log-rank test